Clinical Trials Directory

Trials / Completed

CompletedNCT02699255

Ventricular Arrhythmias After Pulmonary Vein Isolation

A Single-center Observational Study to Examine the Occurrence of Ventricular Arrhythmias After Pulmonary Vein Isolation

Status
Completed
Phase
Study type
Observational
Enrollment
111 (actual)
Sponsor
Universitätsklinikum Hamburg-Eppendorf · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The investigators study aimed to observe the occurrence of new premature ventricular complexes and other ventricular arrhythmias after pulmonary vein isolation.

Detailed description

Atrial fibrillation is the most common arrhythmia with a lifetime risk for development of over 20%. Pulmonary vein isolation is now established as therapy of choice for patients with symptomatic atrial fibrillation. It is well known that this interventional therapy inevitably modulates the intracardiac autonomic nervous system. While this ablation might alter atrial electrophysiology beneficially, the impact on ventricular electrophysiology remains unclear.

Conditions

Timeline

Start date
2014-10-01
Primary completion
2017-01-27
Completion
2017-01-27
First posted
2016-03-04
Last updated
2019-06-07

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02699255. Inclusion in this directory is not an endorsement.